Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Care Olanzilacontinin 10mg/10mg Tablets Safety NetAthens, GA 3023.
Worldwide shipping to healthylife.com.au. This is healthylife’s main international shipping option for all orders over £10. Any international or countrywide shipping option is always available for your needs.
Beware of Unlicensed This product is a prescription only medication. You will need to speak with a healthcare professional before you can use this product. Bazaar-voice your product if you are a buyer/reseller/pharmacy/ laboratory/home improvement/signalling/retail pharmacy.Product information: Description/Information on this product: Healthylife offers prescription only products. You will not use this product for medical or urgent needs, only to buy medications. This medicine is for external use only. It is not indicated for use in children and adolescents under the age of 18. This medicine is not for immediate relief or for long-term use. Not intended for immediate relief or for long-term use. If you have any questions about this or any other product, please read the label or contact the manufacturer at bazaar value. Healthylife does not endorse or recommend this product as the right medicine for you. This medicine is not indicated for use in children under the age of 18. Healthylife’s disclaiming of all responsibility for any part of the product packaging cannot be considered adequate substitute for professional medical advice regarding addiction and addiction-related illnesses.Disclaimer: The information contained herein is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your concerns with your doctor. If you have been diagnosed with a health condition, you should not end the care in future with doubtful consideration. This product information is for informational purposes only and is not intended to substitute for the advice of your healthcare provider or other health care provider. You should not use this information to diagnose or treat any illness, drug or disease, or disease. If you think any health condition may be contributing to your symptoms, you should not have any chest pains, dizziness or fainting while having sex. You should also avoid driving after taking this medicine. Sexual activity may increase the risk for heart disease and stroke. If you are having chest pain, then you should seek immediate medical help. If you are having trouble sleeping, or if you are appetite changes, make sure to get medical help immediately. This is not recommendage for everyone. Be patient and take care while using this medicine. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, take only that dose.
Drug Uses
Strattera, also known as Adderall, is used to treat attention deficit hyperactivity disorder (ADHD). It works by increasing the levels of certain chemicals in the brain that help improve attention and focus. In some cases, it may be used as an antipsychotic to treat schizophrenia and bipolar disorder.
How to Take Strattera
The usual recommended dose of Strattera is 30 mg orally, taken once a day. However, if the patient is taking other medications for ADHD, the dose may be increased by a maximum of 100 mg. It's essential to follow the doctor's instructions carefully and not to increase the dose without careful monitoring and supervision.
Some medications and stimulants may also interact with Strattera. Inform your doctor if you have any allergies, liver problems, or any other medical conditions.
Adverse Reactions
Adverse reactions with Strattera may include:
• Difficulty falling asleep or staying asleep
• Constipation, dry mouth
• Dizziness
• Insomnia
• Increased blood pressure, heart attack, stroke, or blood clots
Storage
Store Strattera between 68°F and 77°F (20°C to 25°C) in a cool, dry place away from children and pets. Store between 59°F to 77°F (15°C to 25°C) in a cool, dry place.
Warnings
Do not take Strattera if:
• you are allergic to atomoxetine
• you have a history of severe heart failure, heart failure, irregular heartbeat, stroke, liver dysfunction, or liver problems
• you have a severe hypersensitivity to atomoxetine
• you are pregnant
• you are taking monoamine oxidase inhibitors (MAOIs) such as isocarboxazid (Marplan), linezolid (Zyvox), methylene blue (Breazeale), phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar, ZelaparZ, Zelapar XR), and tranylcypromine (Parnate)
Pregnancy Warning:
Strattera may pass into the breast milk, but should not be taken by women who are breastfeeding. The safety and effectiveness of Strattera for the treatment of ADHD has not been established, nor has it been studied in humans. The drug may harm an unborn baby.
Strattera is not recommended for use in children under the age of 18 years. It should not be taken in conjunction with stimulants, anticonvulsants, or central nervous system depressants.Strattera may cause dizziness. It should be used with caution in patients with hypertension, heart failure, or cerebrovascular disease.
In patients with a history of cardiovascular disease, consider Strattera as a first-line treatment, especially in the presence of a high blood pressure.
The use of Strattera in children under the age of 18 years is not recommended. Strattera should not be used by children below the age of 18 years.
Interactions
Strattera may have some interactions with other medications. For example, atomoxetine may interact with other medications in the same class, such as buspirone (Buspar), phenelzine (Nardil), and tranylcypromine (Parnate).
When Strattera is used in combination with other medications or stimulants, it should be avoided.
Strattera should not be taken in conjunction with monoamine oxidase inhibitors (MAOIs) or central nervous system depressants.
The use of Strattera in patients with a history of seizures should be under strict medical supervision. Strattera may be associated with the use of other seizure medications, such as carbamazepine (Carbatrol), phenytoin (Dilantin), and phenobarbital.
Pfizer has discovered a new, affordable option for treating ADHD, dubbed Strattera, which combines a stimulant medication with an amphetamine for improved attention and energy levels.
The company announced that a prescription of the drug, known as Strattera, has been approved for adults who meet the American Academy of Child and Adolescent Psychiatry’s criteria for ADHD, and who are 18 and older.
Pfizer, which is based in Indianapolis, has been marketing Strattera for more than 30 years. It's estimated that Strattera has more than $1 billion in sales in the United States, and is a hit for both children and adults.
Pfizer has been working with the U. S. Food and Drug Administration (FDA) on a new ADHD treatment, known as Strattera, for children. The company has also been working with healthcare professionals in the United Kingdom, New York, and Singapore, to explore options to improve ADHD symptoms and help people find relief from their symptoms.
Pfizer also has a partnership with Eli Lilly and Company, an integrated healthcare business that provides prescription medications, over-the-counter and online.
“We’re thrilled to work with Pfizer, a leader in the field of ADHD, to explore the latest advancements in the treatment of this common neurodevelopmental disorder,” said Steve Schoenberg, CEO of the pharmaceutical company. “Pfizer continues to explore other options for people to explore, but their research and development is the closest we have ever been to a new treatment option for ADHD.”
The U. Food and Drug Administration approved Strattera in 2002, which works on the same mechanism of action, as a treatment for ADHD and attention deficit hyperactivity disorder (ADHD).
The drug's effectiveness was established through a study showing that taking it increased attention and hyperactivity in children with ADHD, while also helping patients with depression and anxiety. Strattera is now available in both prescription and over-the-counter forms, with doses of 80 mg and 100 mg being available over the counter.
At the FDA’s latest advisory committee meeting on Strattera, the drug's approval was also based on a review of studies and data showing the drug's effectiveness.
The drug has since been approved for use in adults, and Strattera is not expected to be on the approved label for children. However, Schoenberg expects that it will be available in the coming years.
Pfizer, along with Eli Lilly, and Eli Lilly and Company, are pleased to announce a partnership with Eli Lilly and Company to develop a treatment for ADHD, known as Strattera. The new treatment will offer a more affordable and effective option for individuals who need it.
Strattera, also known as Adderall, is a non-stimulant medication that helps with attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADP). Strattera works by increasing the amount of norepinephrine in the brain, which helps improve focus and concentration. Additionally, Strattera is approved for children's treatment of ADHD, and may be prescribed to adults who have difficulty keeping their minds up all day and have ADHD symptoms.
In clinical trials, Strattera has demonstrated its ability to improve ADHD symptoms and reduce the severity of symptoms in adults with ADHD.
“We’re excited to work with Eli Lilly and Company and have been working closely with their FDA counterparts to explore alternative treatments for ADHD and to work with our clinical team to develop an innovative treatment for ADHD,” said Schoenberg, President and CEO of the Eli Lilly & Company Healthcare business. “At the same time, we’re working with the U.
If you or a loved one is struggling with medication errors or receiving ineffective medications, there are direct solutions and solutions available.
Strategies to minimize medication errors include:
Strategies for Minimizing Drug Errors include:
Strategies to Minimize Medication Errors include:
Stade de France Pharmacy